FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3120714907> ?p ?o ?g. }

• W3120714907 endingPage "S559" @default.
• W3120714907 startingPage "S559" @default.
• W3120714907 abstract "Abstract Background With the advent of directly acting antiviral agents, HCV cure rates exceed 90% in real world studies with an excellent safety profile, but viral load tests of cure are expensive and may limit access to treatment, especially in resource-limited settings. Elevated alanine aminotransferase (ALT) has been shown to correlate with hepatocellular damage. Few studies have evaluated the use of ALT in direct acting antiviral (DAA) treated HCV patients post-treatment as a marker of treatment success. In this large retrospective cohort study, we evaluated the ability of serum ALT level at SVR to predict treatment outcome. Methods We collected baseline demographics, treatment characteristics, and outcomes of DAA-treated patients treated between January 2015 through January 2019 in the VA Maryland Healthcare System as standard of care, and patients in federally qualified health centers in Washington, DC treated between May and November 2015 in the ASCEND study (NCT02339038). Using the ASCEND study as a training set and VA data as the confirmatory set, receiver operating curves (ROC) were generated to determine the predictive value of ALT at SVR for treatment outcome. Results In total, 1415 patients were included, with 1010 patients from the VA and 405 from the ASCEND cohort. We found 96% (n=1360) of patients achieved SVR; &lt; 4% (n =55) relapsed. Baseline demographics are in Table 1. The ALT at SVR were 21.19 IU/L (SD 13.98) and 17.89 IU/L (SD 11.62) in the VA and ASCEND data, respectively compared to 57.84 (SD 41.06) and 42.53 (SD 19.61) who relapsed. With the VA and ASCEND data combined, the mean ALT at SVR was 20.25 (SD 13.43) in comparison to an ALT of 53.11 (SD 36.33) for those patients who relapsed. ROC analysis revealed that ALT &gt; 22 predicted an increased risk of relapse (Figure 1). Table 1:Characteristics of Subjects Completing Hepatitis C Treatment Figure 1: ROC Curve Conclusion In this real-world cohort, we found that ALT greater than 22 at SVR corresponded with an increased risk of relapse and was independent of variables previously associated with relapse, including HIV coinfection status, sex, treatment history, and fibrosis staging. Limiting HCV viral load testing to patients with ALT &gt; 22 at SVR may reduce the overall burden of HCV treatment costs for the majority of HCV treated patients. Disclosures Shyam Kottilil, MD PhD, Arbutus Pharmaceuticals (Grant/Research Support)Gilead Sciences (Grant/Research Support)Merck Inc (Grant/Research Support, Advisor or Review Panel member)" @default.
• W3120714907 created "2021-01-18" @default.
• W3120714907 creator A5015530556 @default.
• W3120714907 creator A5043752885 @default.
• W3120714907 creator A5046839352 @default.
• W3120714907 creator A5056912599 @default.
• W3120714907 creator A5060505702 @default.
• W3120714907 creator A5082384961 @default.
• W3120714907 date "2020-10-01" @default.
• W3120714907 modified "2023-10-16" @default.
• W3120714907 title "1060. Evaluation of ALT at Sustained Virologic Response (SVR) in Patients with Treated Hepatitis C Virus (HCV) Infection" @default.
• W3120714907 doi "https://doi.org/10.1093/ofid/ofaa439.1246" @default.
• W3120714907 hasPublicationYear "2020" @default.
• W3120714907 type Work @default.
• W3120714907 sameAs 3120714907 @default.
• W3120714907 citedByCount "0" @default.
• W3120714907 crossrefType "journal-article" @default.
• W3120714907 hasAuthorship W3120714907A5015530556 @default.
• W3120714907 hasAuthorship W3120714907A5043752885 @default.
• W3120714907 hasAuthorship W3120714907A5046839352 @default.
• W3120714907 hasAuthorship W3120714907A5056912599 @default.
• W3120714907 hasAuthorship W3120714907A5060505702 @default.
• W3120714907 hasAuthorship W3120714907A5082384961 @default.
• W3120714907 hasBestOaLocation W31207149071 @default.
• W3120714907 hasConcept C126322002 @default.
• W3120714907 hasConcept C142462285 @default.
• W3120714907 hasConcept C144024400 @default.
• W3120714907 hasConcept C149923435 @default.
• W3120714907 hasConcept C167135981 @default.
• W3120714907 hasConcept C203014093 @default.
• W3120714907 hasConcept C2522874641 @default.
• W3120714907 hasConcept C2776408679 @default.
• W3120714907 hasConcept C2776455275 @default.
• W3120714907 hasConcept C2778606649 @default.
• W3120714907 hasConcept C2780084366 @default.
• W3120714907 hasConcept C2992872382 @default.
• W3120714907 hasConcept C3013748606 @default.
• W3120714907 hasConcept C58471807 @default.
• W3120714907 hasConcept C71924100 @default.
• W3120714907 hasConcept C72563966 @default.
• W3120714907 hasConcept C90924648 @default.
• W3120714907 hasConceptScore W3120714907C126322002 @default.
• W3120714907 hasConceptScore W3120714907C142462285 @default.
• W3120714907 hasConceptScore W3120714907C144024400 @default.
• W3120714907 hasConceptScore W3120714907C149923435 @default.
• W3120714907 hasConceptScore W3120714907C167135981 @default.
• W3120714907 hasConceptScore W3120714907C203014093 @default.
• W3120714907 hasConceptScore W3120714907C2522874641 @default.
• W3120714907 hasConceptScore W3120714907C2776408679 @default.
• W3120714907 hasConceptScore W3120714907C2776455275 @default.
• W3120714907 hasConceptScore W3120714907C2778606649 @default.
• W3120714907 hasConceptScore W3120714907C2780084366 @default.
• W3120714907 hasConceptScore W3120714907C2992872382 @default.
• W3120714907 hasConceptScore W3120714907C3013748606 @default.
• W3120714907 hasConceptScore W3120714907C58471807 @default.
• W3120714907 hasConceptScore W3120714907C71924100 @default.
• W3120714907 hasConceptScore W3120714907C72563966 @default.
• W3120714907 hasConceptScore W3120714907C90924648 @default.
• W3120714907 hasIssue "Supplement_1" @default.
• W3120714907 hasLocation W31207149071 @default.
• W3120714907 hasLocation W31207149072 @default.
• W3120714907 hasLocation W31207149073 @default.
• W3120714907 hasOpenAccess W3120714907 @default.
• W3120714907 hasPrimaryLocation W31207149071 @default.
• W3120714907 hasRelatedWork W2000510929 @default.
• W3120714907 hasRelatedWork W2003092423 @default.
• W3120714907 hasRelatedWork W2021929421 @default.
• W3120714907 hasRelatedWork W2059953419 @default.
• W3120714907 hasRelatedWork W2376817579 @default.
• W3120714907 hasRelatedWork W2734590811 @default.
• W3120714907 hasRelatedWork W2739774394 @default.
• W3120714907 hasRelatedWork W3032593328 @default.
• W3120714907 hasRelatedWork W3125096972 @default.
• W3120714907 hasRelatedWork W48420099 @default.
• W3120714907 hasVolume "7" @default.
• W3120714907 isParatext "false" @default.
• W3120714907 isRetracted "false" @default.
• W3120714907 magId "3120714907" @default.
• W3120714907 workType "article" @default.